Literature DB >> 21081729

Diagnosis, microbial epidemiology, and antibiotic treatment of acute otitis media in children: a systematic review.

Tumaini R Coker1, Linda S Chan, Sydne J Newberry, Mary Ann Limbos, Marika J Suttorp, Paul G Shekelle, Glenn S Takata.   

Abstract

CONTEXT: Acute otitis media (AOM) is the most common condition for which antibiotics are prescribed for US children; however, wide variation exists in diagnosis and treatment.
OBJECTIVES: To perform a systematic review on AOM diagnosis, treatment, and the association of heptavalent pneumococcal conjugate vaccine (PCV7) use with AOM microbiology. DATA SOURCES: PubMed, Cochrane Databases, and Web of Science, searched to identify articles published from January 1999 through July 2010. STUDY SELECTION: Diagnostic studies with a criterion standard, observational studies and randomized controlled trials comparing AOM microbiology with and without PCV7, and randomized controlled trials assessing antibiotic treatment. DATA EXTRACTION: Independent article review and study quality assessment by 2 investigators with consensus resolution of discrepancies.
RESULTS: Of 8945 citations screened, 135 were included. Meta-analysis was performed for comparisons with 3 or more trials. Few studies examined diagnosis; otoscopic findings of tympanic membrane bulging (positive likelihood ratio, 51 [95% confidence interval {CI}, 36-73]) and redness (positive likelihood ratio, 8.4 [95% CI, 7-11]) were associated with accurate diagnosis. In the few available studies, prevalence of Streptococcus pneumoniae decreased (eg, 33%-48% vs 23%-31% of AOM isolates), while that of Haemophilus influenzae increased (41%-43% vs 56%-57%) pre- vs post-PCV7. Short-term clinical success was higher for immediate use of ampicillin or amoxicillin vs placebo (73% vs 60%; pooled rate difference, 12% [95% CI, 5%-18%]; number needed to treat, 9 [95% CI, 6-20]), while increasing the rate of rash or diarrhea by 3% to 5%. Two of 4 studies showed greater clinical success for immediate vs delayed antibiotics (95% vs 80%; rate difference, 15% [95% CI, 6%-24%] and 86% vs 70%; rate difference, 16% [95% CI, 6%-26%]). Data are absent on long-term effects on antimicrobial resistance. Meta-analyses in general showed no significant differences in antibiotic comparative effectiveness.
CONCLUSIONS: Otoscopic findings are critical to accurate AOM diagnosis. AOM microbiology has changed with use of PCV7. Antibiotics are modestly more effective than no treatment but cause adverse effects in 4% to 10% of children. Most antibiotics have comparable clinical success.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21081729     DOI: 10.1001/jama.2010.1651

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  75 in total

1.  Small Ideas for Saving Big Health Care Dollars.

Authors:  Jodi L Liu; Deborah Lai; Jeanne S Ringel; Mary E Vaiana; Jeffrey Wasserman
Journal:  Rand Health Q       Date:  2014-03-01

2.  Comparative Profile of Heme Acquisition Genes in Disease-Causing and Colonizing Nontypeable Haemophilus influenzae and Haemophilus haemolyticus.

Authors:  Nurul I Hariadi; Lixin Zhang; Mayuri Patel; Sara A Sandstedt; Gregg S Davis; Carl F Marrs; Janet R Gilsdorf
Journal:  J Clin Microbiol       Date:  2015-04-22       Impact factor: 5.948

Review 3.  Antibiotic Allergy in Pediatrics.

Authors:  Allison Eaddy Norton; Katherine Konvinse; Elizabeth J Phillips; Ana Dioun Broyles
Journal:  Pediatrics       Date:  2018-05       Impact factor: 7.124

4.  Impact of the 13-valent pneumococcal conjugate vaccine on the incidences of acute otitis media, recurrent otitis media and tympanostomy tube insertion in children after its implementation into the national immunization program in Turkey.

Authors:  Ahmet Soysal; Erdem Gönüllü; Ismail Yıldız; Gökhan Aydemir; Turan Tunç; Yezdan Fırat; Burak Erdamar; Metin Karaböcüoğlu
Journal:  Hum Vaccin Immunother       Date:  2019-09-05       Impact factor: 3.452

5.  Invasive pneumococcal disease in children can reveal a primary immunodeficiency.

Authors:  Jean Gaschignard; Corinne Levy; Maya Chrabieh; Bertrand Boisson; Cécile Bost-Bru; Stéphane Dauger; François Dubos; Philippe Durand; Joël Gaudelus; Dominique Gendrel; Christèle Gras Le Guen; Emmanuel Grimprel; Gaël Guyon; Catherine Jeudy; Eric Jeziorski; Francis Leclerc; Pierre-Louis Léger; Fabrice Lesage; Mathie Lorrot; Isabelle Pellier; Didier Pinquier; Loïc de Pontual; Philippe Sachs; Caroline Thomas; Pierre Tissières; Frédéric V Valla; Philippe Desprez; Véronique Frémeaux-Bacchi; Emmanuelle Varon; Xavier Bossuyt; Robert Cohen; Laurent Abel; Jean-Laurent Casanova; Anne Puel; Capucine Picard
Journal:  Clin Infect Dis       Date:  2014-04-23       Impact factor: 9.079

Review 6.  The Role of Breastfeeding in Childhood Otitis Media.

Authors:  Caroline J Lodge; Gayan Bowatte; Melanie C Matheson; Shyamali C Dharmage
Journal:  Curr Allergy Asthma Rep       Date:  2016-09       Impact factor: 4.806

7.  Serum vitamin D levels in children with recurrent otitis media.

Authors:  Atilla Cayir; Mehmet Ibrahim Turan; Ozalkan Ozkan; Yasemin Cayir; Avni Kaya; Salih Davutoglu; Behzat Ozkan
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-03-30       Impact factor: 2.503

8.  Complete Deletion of the Fucose Operon in Haemophilus influenzae Is Associated with a Cluster in Multilocus Sequence Analysis-Based Phylogenetic Group II Related to Haemophilus haemolyticus: Implications for Identification and Typing.

Authors:  Camilla de Gier; Lea-Ann S Kirkham; Niels Nørskov-Lauritsen
Journal:  J Clin Microbiol       Date:  2015-09-16       Impact factor: 5.948

Review 9.  [Acute otitis media in children: antibiotic therapy or watchful waiting?].

Authors:  P Amrhein; A Hospach; C Sittel; A Koitschev
Journal:  HNO       Date:  2013-05       Impact factor: 1.284

10.  A retrospective evaluation of microbiology of acute otitis media complicated by spontaneous otorrhea in children living in Milan, Italy.

Authors:  P Marchisio; S Bianchini; E Baggi; M Fattizzo; C Galeone; S Torretta; N Principi; S Esposito
Journal:  Infection       Date:  2012-12-05       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.